Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Size By Type (Drug Eluting Balloons, Normal Balloons), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to...

The Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market was valued at USD 2.1 billion in 2023 and is projected to surpass USD 3.5 billion by 2031, growing at a CAGR of 6.1% during the forecast period of 2023-2031. The growth of the market is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) globally, increasing demand for minimally invasive procedures, and continuous advancements in PTA balloon technologies. PTA balloons are essential medical devices used to treat narrowed or blocked blood vessels, improving blood flow without the need for major surgery.

Drivers:

Rising Prevalence of Cardiovascular Diseases:

The increasing incidence of peripheral artery disease (PAD) and coronary artery disease (CAD) is a significant driver for the PTA balloons market. Factors such as sedentary lifestyles, smoking, diabetes, and obesity are contributing to the global burden of cardiovascular diseases, necessitating effective treatment solutions like PTA balloons.

Growing Preference for Minimally Invasive Procedures:

Patients and healthcare providers are increasingly favoring minimally invasive procedures due to reduced recovery times, lower risk of complications, and cost-effectiveness. PTA balloon angioplasty offers a less invasive alternative to traditional surgeries, driving market demand.

Technological Advancements in PTA Balloons:

The introduction of drug-coated balloons, scoring balloons, and cutting-edge material innovations for enhanced flexibility and deliverability is fueling the adoption of PTA balloons in vascular interventions.

Restraints:

High Cost of Advanced PTA Balloons:

The cost of drug-coated and specialized PTA balloons can be prohibitive, especially in emerging economies. High procedure costs may limit the widespread adoption of these devices in low- and middle-income regions.

Risk of Restenosis:

Despite technological advancements, the risk of restenosis (re-narrowing of the artery) post-procedure remains a concern, which may affect market growth.

Opportunity:

Expansion in Emerging Markets:

The growing healthcare infrastructure and increasing awareness regarding cardiovascular health in regions like Asia-Pacific, Latin America, and the Middle East present substantial growth opportunities for PTA balloon manufacturers.

Rising Adoption of Drug-Coated Balloons:

Drug-coated PTA balloons, which help reduce restenosis rates, are gaining significant traction. Ongoing clinical trials and regulatory approvals for new drug-coated balloon products are expected to open new revenue streams for market players.

Market by System Type Insights:

Based on system type, the Drug-Coated PTA Balloons segment accounted for the largest market share in 2023. This segment's dominance is attributed to its superior efficacy in reducing restenosis rates compared to plain balloons. Additionally, Specialty Balloons like scoring and cutting balloons are expected to witness the highest growth during the forecast period due to their enhanced precision and effectiveness in complex lesions.

Market by End-use Insights:

Hospitals emerged as the largest end-use segment in 2023, contributing over 55% of the market share. The availability of advanced infrastructure and skilled professionals in hospitals drives this segment. Ambulatory Surgical Centers (ASCs) are anticipated to witness substantial growth owing to the increasing preference for outpatient procedures and cost-effective treatment settings.

Market by Regional Insights:

Geographically, North America dominated the global PTA balloons market in 2023, accounting for the largest share due to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and early adoption of innovative medical technologies. The Asia-Pacific region is expected to register the highest growth rate during the forecast period, driven by the rising geriatric population, improving healthcare facilities, and increasing patient awareness.

Competitive Scenario:

Key players operating in the Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market include:

Medtronic plc

Boston Scientific Corporation

B. Braun Melsungen AG

Abbott Laboratories

Biotronik SE & Co. KG

Cardinal Health, Inc.

Cook Medical LLC

Terumo Corporation

Koninklijke Philips N.V.

Cordis (A Cardinal Health Company)

These companies focus on product innovation, strategic collaborations, mergers & acquisitions, and regional expansions to strengthen their market positions.

Key Market Developments:

In 2023, Medtronic plc launched a next-generation drug-coated PTA balloon designed to enhance drug delivery and reduce restenosis rates in complex lesions.

In 2024, Boston Scientific Corporation expanded its portfolio of scoring PTA balloons, offering better precision for calcified lesions.

In 2025, Abbott Laboratories announced strategic partnerships with regional healthcare providers in Asia-Pacific to strengthen its presence in emerging markets.

Scope of Work – Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 3.5 billion

CAGR (2023-2031) 6.1%

Key Segments by System Type Drug-Coated PTA Balloons, Plain PTA Balloons, Specialty PTA Balloons

Key Segments by End-use Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Leading Region North America

Key Players Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Abbott Laboratories, Biotronik SE & Co. KG

FAQs:

1. What is the current market size of the Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market?

The market size was valued at USD 2.1 billion in 2023.

2. What is the major growth driver of the Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market?

The rising prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures are the key drivers.

3. Which is the largest region during the forecast period in the Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market?

North America is the largest region, driven by advanced healthcare infrastructure and a high patient population suffering from cardiovascular diseases.

4. Which segment accounted for the largest market share in the Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market?

The Drug-Coated PTA Balloons segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market?

Key players include Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Abbott Laboratories, and Biotronik SE & Co. KG.